Jaguar Health Inc (NASDAQ:JAGX) shares, rose in value, with the stock price up by 0.06% to the previous day’s close as strong demand from buyers drove the stock to $0.17.
Actively observing the price movement in the last trading, the stock closed the session at $0.17. The value of beta (5-year monthly) was 1.38. Referring to stock’s 52-week performance, its high was $1.22, and the low was $0.05. On the whole, JAGX has fluctuated by 146.38% over the past month.
With the market capitalization of Jaguar Health Inc currently standing at about $46.96 million, investors are eagerly awaiting this quarter’s results, scheduled for May 13, 2024 – May 17, 2024.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that JAGX’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of JAGX currently trading nearly 44.75% and 83.25% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 63.99, while the 7-day volatility ratio is showing 16.94% which for the 30-day chart, stands at 22.95%. Furthermore, Jaguar Health Inc (JAGX)’s beta value is 1.10, and its average true range (ATR) is 0.03.
A comparison of Jaguar Health Inc (JAGX) with its peers suggests the former has fared considerably weaker in the market. JAGX showed an intraday change of 0.06% in last session, and over the past year, it shrunk by -64.36%%.
Data on historical trading for Jaguar Health Inc (NASDAQ:JAGX) indicates that the trading volumes over the past 3 months, they’ve averaged 61.45 million. According to company’s latest data on outstanding shares, there are 276.22 million shares outstanding.
Nearly 4.90% of Jaguar Health Inc’s shares belong to company insiders and institutional investors own 0.45% of the company’s shares. The stock has risen by 12.29% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the JAGX stock heading into the next quarter.
